An opportunity to help further research into treatments for open-angle glaucoma is now open to adults who have been diagnosed with this condition. Volunteers will play an important role in this study by enabling researchers to study the safety and effectiveness of the investigational drug when it is injected into the eye.
Five Australians are among an international team of scientists who have discovered a new gene mutation that may be a root cause of severe cases of childhood glaucoma.
The concept of delivering a drug to protect retinal ganglion cells (RGCs) is not something that is currently done clinically, but as a complement to IOP lowering, may be an important glaucoma management tool.
A 12-month clinical trial to examine the validity of home-monitoring for glaucoma patients using a novel software app has been successfully completed by a team of Australian researchers.
A recent study from the New York Eye and Ear Infirmary of Mount Sinai showed that being of African heritage increased the risk of vision loss due to glaucoma.
An invited review of the available literature on migraine and its impact on testing for glaucoma was published in 2016.
The first patient has been enrolled in a prospective, randomised, multicentre study to investigate canaloplasty with the new iTrack Advance CATALYST Study.
Given the convincing findings from the Age-Related Eye Disease Study (AREDS) on supplement recommendations in slowing down progression of age-related macular degeneration (AMD), it is not surprising that the role of diet and supplements has also been examined in glaucoma management.
In this study, researchers are testing an investigational drug for adults with ocular hypertension.